North America Body Temperature Monitoring Market Size

North America Body Temperature Monitoring Market Analysis

The North America Body Temperature Monitoring Market size is estimated at USD 0.76 billion in 2024, and is expected to reach USD 1.11 billion by 2029, growing at a CAGR of 8.17% during the forecast period (2024-2029).

• Due to the COVID-19 pandemic, the high prevalence of COVID-19 infections in North American countries resulted in an increased demand for body temperature monitoring solutions, which resulted in increased product launches. For instance, in February 2021, LEPU Intelligence Medical Equipment Co., Ltd., a subsidiary of Lepu Medical, received approval from the United States Food Drug Administration (FDA) for three of its infrared forehead thermometers, namely LFR30B, LFR50, and LFR60. Thus, owing to the COVID-19 pandemic, the usage of thermometers increased significantly. However, as the pandemic subsided, the usage of body temperature monitoring solutions, the studied market is expected to have stable growth during the forecast period of the study.
• The major factors contributing to the growth of the North American body temperature monitoring market are the rise of infectious conditions such as influenza, respiratory syncytial virus (RSV), and others, the increasing pediatric population, and the increasing demand for disposable thermometers and digital thermometers.
• The increasing prevalence of infectious diseases in the region is a major factor driving the market growth as infectious diseases are often associated with high fever, which is expected to increase the usage of body temperature monitoring solutions. For instance, according to the data published by the Pan American Health Organization (PAHO) in October 2022, a total of 29,829 Zika virus infection cases have been reported in the Region of the Americas in 13 out of 52 countries and territories. Out of all reported cases, 2,391 cases were lab-confirmed, which constitutes about 8% of the total cases. The 29,829 represents a cumulative incidence of 3.02 cases per 100,000 population in the Americas.
• Furthermore, according to the same source, a total of 2,32,204 chikungunya infection cases were reported in 12 of the 52 countries and territories in the Americas, out of which 1,10,805 were confirmed and it constitutes about 47.7% of the total cases. The regional cumulative incidence of chikungunya in 2022 was 23.50 cases per 100,000 population in the Americas.
• Furthermore, according to the data updated by the Government of Canada in November 2022, overall influenza activity was increasing and above expected levels. An estimated 2,234 detections were made, with an 11.7% positivity rate. Influenza activity was above the seasonal threshold of 5% of tests positive, which indicated the beginning of the influenza epidemic at the national level.
• Moreover, the developments by market players in the region also enhanced the market growth. For instance, in June 2021, Shenzhen Sonida Digital Technology Co., Ltd received 510 (k) premarketing approval from the United States Food and Drug Administration (FDA) for their infrared thermometer. Also, in June 2021, Masimo Corporation received 510 (k) premarketing approval from the United States FDA for their Radius T Wearable Thermometer.
• Thus, the aforementioned factors, such as the rising prevalence of infectious diseases, are expected to boost the market growth. However, issues related to thermometers are expected to impede market growth.